TP53 and lung cancer: For example, transduction of wild-type p53 in a mutant p53-expressing human lung cancer cell via a recombinant adenovirus vector was demonstrated to reduce the tumour growth in vivo, in part by a bystander effect mediated by the antiangiogenesis mechanism (Nishizaki et al, 1999).